शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

BSETRIOCHEM PRODUCTS LTD.· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 4 Nov, 2026 · 15:54 IST

Unaudited standalone September 2026 revenue falls 43%, profit Rs 8.40 lakh

Revenue declinedEBITDA margin expansionResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

Standalone revenue from operations in the September 2026 quarter was Rs 16.72 lakh, down 43.4% from Rs 29.52 lakh last year; profit after tax was Rs 8.40 lakh versus a Rs 19.26 lakh loss. Standalone half-year revenue was Rs 33.28 lakh versus Rs 51.62 lakh; profit after tax was Rs 17.88 lakh versus a Rs 22.32 lakh loss. Standalone half-year operating activities used Rs 31.59 lakh of cash, versus Rs 47.25 lakh last year. Previous results were recast.

Likely market impact

Lower sales and continued cash use from operations weigh on the stock. The return to profit helps, but the small revenue base limits confidence.

By the numbersStandalone · Q2 FY27 vs Q2 FY26
Q2 FY27Q2 FY26Change
Revenue₹0.00 Cr₹0.00 Crunchanged
Operating profit−₹0.06 Cr−₹0.44 Crloss narrowed
Profit after tax₹0.08 Cr−₹0.19 Crturned positive
EBITDA margin———

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.